Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-08-12 8:52 pm Sale | 2025-06-30 | 13G | SOLENO THERAPEUTICS INC PA SLNO | Vivo Opportunity Fund Holdings, L.P. | 3,958,294 7.400% | -500,000 (-11.22%) | Filing History |
| 2025-08-12 8:50 pm Purchase | 2025-06-30 | 13G | CIDARA THERAPEUTICS INC NE CDTX | Vivo Opportunity Fund Holdings, L.P. | 1,175,796 4.600% | 563,520 (+92.04%) | Filing History |
| 2025-05-15 08:35 am Sale | 2025-03-31 | 13G | REGULUS THERAPEUTICS INC P RGLS | Vivo Opportunity Fund Holdings, L.P. | 2,696,426 3.900% | -2,303,574 (-46.07%) | Filing History |
| 2025-05-15 08:33 am Sale | 2025-03-31 | 13G | DELCATH SYS INC DCTH | Vivo Opportunity Fund Holdings, L.P. | 750,195 2.200% | -958,384 (-56.09%) | Filing History |
| 2025-05-15 08:32 am Purchase | 2025-03-31 | 13G | COMPASS PATHWAYS PLC SPONSORED CMPS | Vivo Opportunity Fund Holdings, L.P. | 6,348,988 6.600% | 3,132,988 (+97.42%) | Filing History |
| 2025-05-15 08:31 am Purchase | 2025-03-31 | 13G | CIDARA THERAPEUTICS INC NE CDTX | Vivo Opportunity Fund Holdings, L.P. | 612,276 4.700% | 12,119 (+2.02%) | Filing History |
| 2025-05-15 08:30 am Unchanged | 2025-03-31 | 13G | UNICYCIVE THERAPEUTICS INC UNCY | Vivo Opportunity Fund Holdings, L.P. | 6,096,173 9.990% | 0 (Unchanged) | Filing History |
| 2025-04-08 6:15 pm Purchase | 2025-04-07 | 13G | DBV TECHNOLOGIES S.A. ADR DBVT | Vivo Opportunity Fund Holdings, L.P. | 20,358,470 9.990% | 20,358,470 (New Position) | Filing History |
| 2025-03-31 8:00 pm Sale | 2025-03-31 | 13G | SOLENO THERAPEUTICS INC PA SLNO | Vivo Opportunity Fund Holdings, L.P. | 4,458,294 9.700% | -1,833,557 (-29.14%) | Filing History |
| 2024-12-09 5:37 pm Purchase | 2024-11-26 | 13G | CIDARA THERAPEUTICS INC NE CDTX | Vivo Opportunity Fund Holdings, L.P. | 600,157 5.500% | 600,157 (New Position) | Filing History |
| 2024-11-21 4:51 pm Purchase | 2024-11-19 | 13G | ACLARIS THERAPEUTICS INC ACRS | Vivo Opportunity Fund Holdings, L.P. | 7,955,160 7.400% | 7,955,160 (New Position) | Filing History |
| 2024-11-14 7:02 pm Sale | 2024-09-30 | 13G | DELCATH SYS INC DCTH | Vivo Opportunity Fund Holdings, L.P. | 1,708,579 5.300% | -1,000,000 (-36.92%) | Filing History |
| 2024-11-14 7:01 pm Purchase | 2024-10-09 | 13G | UNICYCIVE THERAPEUTICS INC UNCY | Vivo Opportunity Fund Holdings, L.P. | 6,096,173 9.990% | 100,000 (+1.67%) | Filing History |
| 2024-11-14 6:59 pm Sale | 2024-09-30 | 13G | REZOLUTE INC RZLT | Vivo Opportunity Fund Holdings, L.P. | 2,797,704 4.800% | -445,138 (-13.73%) | Filing History |
| 2024-11-14 6:57 pm Sale | 2024-09-30 | 13G | ADVERUM BIOTECHNOLOGIES INC CO ADVM | Vivo Opportunity Fund Holdings, L.P. | 218,895 1.100% | -1,281,105 (-85.41%) | Filing History |
| 2024-09-05 6:37 pm Sale | 2024-08-27 | 13G | SOLENO THERAPEUTICS INC PA SLNO | Vivo Opportunity Fund Holdings, L.P. | 6,291,851 16.200% | -1,025,000 (-14.01%) | Filing History |
| 2024-08-14 6:47 pm Purchase | 2024-08-08 | 13G | TENAX THERAPEUTICS INC PAR TENX | Vivo Opportunity Fund Holdings, L.P. | 6,249,990 9.990% | 6,249,990 (New Position) | Filing History |
| 2024-05-01 1:07 pm Sale | 2024-04-29 | 13D | SOLENO THERAPEUTICS INC PA SLNO | Vivo Opportunity Fund Holdings, L.P. | 7,316,851 22.500% | -1,101,242 (-13.08%) | Filing History |
| 2024-03-20 4:30 pm Purchase | 2024-03-14 | 13G | REGULUS THERAPEUTICS INC P RGLS | Vivo Opportunity Fund Holdings, L.P. | 5,000,000 7.700% | 5,000,000 (New Position) | Filing History |
| 2024-02-14 4:30 pm Purchase | 2024-02-07 | 13G | ADVERUM BIOTECHNOLOGIES INC CO ADVM | Vivo Opportunity Fund Holdings, L.P. | 1,500,000 7.200% | 1,500,000 (New Position) | Filing History |